Novel imaging mass cytometry (IMC) technology enables a closer look at tumor microenvironment post-pelareorep/atezolizumab/letrozole treatment Affirms pelareorep’s ability to increase PD-L1 positive cells and T cell infiltration in the tumor microenvironment Data will support conduct of…
